Financials data is unavailable for this security.
Cash flow in USDView more
In 2023, Panbela Therapeutics Inc increased its cash reserves by 100.62%, or 1.29m. Cash Flow from Financing totalled 26.14m or -- of revenues. In addition the company used 25.25m for operations while cash from investing totalled 400.00k.
Cash flow per share | -13.66 |
---|---|
Price/Cash flow per share | -- |
Book value per share | -2.18 |
---|---|
Tangible book value per share | -2.18 |
More ▼
Balance sheet in USDView more
Current ratio | 0.046 |
---|---|
Quick ratio | -- |
Total debt/total equity | -- |
---|---|
Total debt/total capital | -- |
More ▼